Exhibit 10.6
STANDARD DISTRIBUTION AGREEMENT
VALUE ADDED RESELLER (VAR)
THIS AGREEMENT is entered into as of the 20 day of June 1998, by and
between HealthGate Data Corp., a Delaware corporation, having an address at 000
Xxxxxxxx Xxxxxx, Xxxxx 000, Xxxxxx, XX 00000 (hereinafter referred to as
"HealthGate") and Data General Corporation a Delaware corporation,
having an address at 0000 Xxxxxxxx Xxxxx, Xxxxxxxxxxx, XX 00000 (hereinafter
referred to as "VAR").
WITNESSETH:
WHEREAS, VAR markets and sells to companies, institutions and other
entities, alone or in combination with others, interactive information,
communication and transactional services (whether presently existing or
hereafter developed referred to herein as the "VAR Services"); and
WHEREAS, HealthGate offers several series of information including the
MEDLINE database and other databases through HealthGate's Internet sites,
including HealthGate's Internet sites having the following URLs:
xxxx://xxx.xxxxxxxxxx.xxx and xxxx://xxXXXX.xxx (the "HealthGate Sites");
WHEREAS, VAR and HealthGate wish to enter into an agreement providing
for VAR to sell and license certain of HealthGate's series of databases
available through the Internet and other HealthGate products and services to
VAR's clients and prospects through a Co-Branded Site (as defined in Section
1.1) designed for the VAR's clients and prospects.
NOW, THEREFORE, in consideration of the mutual promises set forth
herein and other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties hereto agree as follows:
I. CO-BRANDED SITE; RELICENSING; AUTHORIZED USERS; LINKS TO CO-BRANDED SITE
1.1 CO-BRANDED SITE. HealthGate will design, develop, host and
maintain, if applicable, a customized site that can be accessed by the
Authorized Users (as defined in Section 1.3) and contain databases and
information, including the HealthGate Series of Products (the "Co-Branded
Site"). Each Co-Branded Site shall be subject to a separate End-User
Agreement, by and among HealthGate, VAR and the Corporate/Institutional
Account (as defined in Section 1.2), substantially in the form of SCHEDULE E
hereto, which sets forth, among other matters, the following: (i) the
specific databases and information available at the Co-Branded Site through
HealthGate; (ii) whether advertising and sponsorship messages shall be
available on the Co-Branded Site; and (iii) specification, customization and
responsibility concerning the design, development, hosting and maintenance of
the Co-Branded Site; and (iv) usage and overage charges
1.2 RELICENSING. VAR shall market, sell and license to institutions,
companies, corporations and other entities ("Corporate/Institutional Accounts")
access to HealthGate Series of Products (as defined in Section 2.1, below)
pursuant to the terms of this Agreement. With the exception of the defined "VAR
Territory", as defined in Schedule D, VAR shall contact HealthGate and register
each prospect in advance of licensing a HealthGate Series of Products to
a Corporate/Institutional Account. HealthGate may reject to the proposed
transaction with the potential Corporate/Institutional Account, if such
Corporate/Institutional Account is outside the VAR Territory.
1.3 AUTHORIZED USERS. For the purposes of this Agreement, "Authorized
User" shall mean (i) Corporate/Institutional Accounts that have been licensed to
access the "Co-Branded Site" pursuant to an End-User Agreement; and (ii) persons
who access a Corporate/Institutional Account through such entity's Intranet or
Internet access pursuant to the terms of the End-User Agreement.
1.4 LINKS TO CO-BRANDED SITE; INTERACTIONS BETWEEN SITES. HealthGate
will accept links from the Corporate/Institutional Account's Internet or
Intranet site(s) to the Co-Branded Site. On the Co-Branded Site, HealthGate will
accept queries posed by an Authorized User and return to the Authorized User the
results of said queries to the Co-Branded Site.
All such interactions between the two sites will be conducted according
to mutually agreed upon standards. The Co-Branded Site shall contain prominent
reference to HealthGate and prominently feature HealthGate's logo in a manner
acceptable to HealthGate. In the event the parties do not mutually agree upon
the interaction standards within 30 days of the date of the applicable End-User
Agreement, such standards shall be established by HealthGate to be consistent
with the interaction standards utilized by HealthGate in its other VAR or
similar arrangements.
II. HEALTHGATE SERIES OF PRODUCTS
2.1 HEALTHGATE SERIES OF PRODUCTS. Following receipt by HealthGate of
the applicable fully- executed End-User Agreement (SCHEDULE E) and VAR purchase
orders, Authorized Users shall have access via the Co-Branded Site to one or
more of the series of databases listed on SCHEDULE A attached hereto (the
"HealthGate Series of Products").
2.2 EXCLUSIVITY. VAR agrees that during the term of this agreement it
shall not market, license or provide links or access from its sites to any other
entity's products or services that are similar in nature to those of HealthGate
Series of Products.
III. FEES
3.1 LICENSE FEES. Annual list price license fees and annual license
fees chargeable by HealthGate to VAR for each of the HealthGate Series of
Products are set forth in SCHEDULE A. Unless otherwise expressly agreed to in
writing by HealthGate, license fees to HealthGate are payable in advance.
3.2 ADVERTISING AND OTHER FEE ARRANGEMENTS. Arrangements concerning
advertising or other fee arrangements, if any, are set forth on SCHEDULE B
attached hereto.
3.3 PROFESSIONAL SERVICES AND CUSTOM DEVELOPMENT (SETUP CHARGES).
Arrangements concerning other professional services, custom development or setup
fees, if any, are set forth on SCHEDULE C attached hereto.
2
3.4 LATE FEES. All late fee payments shall accrue interest at the rate
of twelve percent (12%) per annum.
IV. TERM AND TERMINATION
4.1 TERM. This Agreement shall be effective on June 20, 1998, and
shall continue in effect until ____, ____ (the "Initial Scheduled Expiration
Date"), unless otherwise terminated as provided hereunder.
4.2 RENEWAL. Unless notice of intent not to renew is given by either
party at least ninety (90) days prior to the then current Scheduled Expiration
Date, this Agreement shall be automatically extended for an additional
twelve-month period.
4.3 TERMINATION FOR BREACH. Each party hereto shall have the right to
terminate this Agreement in the event that the other party has materially
breached this Agreement; provided, however, that no such termination shall be
effective unless (i) the terminating party provides at least ten (10) days
written notice (the "Termination Notice") to the other party setting forth the
facts and circumstances constituting the breach, and (ii) the party alleged to
be in default does not cure such default within thirty (30) days following
receipt of the Termination Notice. In the event that the nature of the default
specified in the Termination Notice cannot be reasonably cured within thirty
(30) days following receipt of the Termination Notice, a party shall not be
deemed to be in default if such party shall, within such thirty (30) day period,
present an agreed upon plan to cure the default, commences curing such default
and thereafter diligently prosecutes the same to completion. If the breach
specified in the Termination Notice is timely cured or cure is commenced and
diligently pursued, as provided above, the Termination Notice shall be deemed
rescinded and the Agreement shall continue in full force and effect.
4.4 POST TERMINATION OBLIGATIONS. (a) PAYMENTS. In the event of any
termination of this Agreement by either party, all fees previously due or owing
by either party as of the date of termination will be immediately due and
payable in full to the other party.
(b) SEVERANCE OF LINKS AND DISCONTINUANCE OF PROMOTION OF CO-BRANDED
SITE. Within ten (10) business days of any termination by either party of this
Agreement, both parties will destroy advertising or promotional materials, if
any, containing any reference to the other party or their products.
(c) CONTINUING ACCESS FOR PAID CORPORATE/INSTITUTIONAL ACCOUNTS.
Notwithstanding the termination of this Agreement, HealthGate shall continue to
make available access to the HealthGate Series of Products to
Corporate/Institutional Accounts following termination of this agreement (i) to
the extent that HealthGate has received prior to such termination from VAR or
such Corporate/Institutional Account prepayment of licensing fees and (ii)
provided such Corporate/Institutional Account was not directly or indirectly
involved in the breach or default giving rise to the termination of this
agreement.
3
V. HEALTHGATE TRADEMARKS
5.1 HEALTHGATE TRADEMARKS. Notwithstanding the limited right to use
HealthGate's name, logo and other marks created or utilized by HealthGate
(collectively the "HealthGate Trademarks") on the Co-Branded Sites, VAR
recognizes and acknowledges HealthGate's representation that HealthGate is the
sole owner of the HealthGate Trademarks and all rights therein and the goodwill
pertaining thereto belong exclusively to HealthGate. VAR recognizes and
acknowledges HealthGate's representation that HealthGate Trademarks have
acquired a secondary meaning and are associated with high quality services and
products available from HealthGate. Accordingly, the VAR is authorized to use
the HealthGate Trademarks in accordance with the applicable trademark laws in
conjunction with the sales and marketing effort surrounding the HealthGate
services to the VAR territory. Any other use of the HealthGate Trademarks is
subject to written approval by HealthGate
VAR acknowledges HealthGate's representation that each HealthGate
Trademark is and will remain the exclusive property of HealthGate and all use by
the Co-Branded Site, Corporate/Institutional Accounts or VAR of any HealthGate
Trademark will inure solely to the benefit of HealthGate. Neither this Agreement
nor any rights granted hereunder will operate as a transfer to VAR or
Corporate/Institutional Accounts or the Co-Branded Site of any rights in or to
any HealthGate Trademark, except for the limited rights expressly granted under
this Agreement. VAR will not take any action that would undermine, conflict
with, or be contrary to the rights and interest of HealthGate, including,
without limitation, any use of, or attempt to register, any trademark, service
xxxx or trade name substantially similar to any HealthGate Trademark.
All advertising and promotional material for the Co-Branded Sites or
the HealthGate Series of Products, which contains any HealthGate Trademark,
shall be subject to review and approval by HealthGate (which approval shall not
be unreasonably withheld).
VI. REPRESENTATIONS, WARRANTIES AND RELATED AGREEMENTS.
6.1 HEALTHGATE'S REPRESENTATIONS AND WARRANTIES. HealthGate represents
and warrants that (i) it has the right and authority to enter into this
Agreement, (ii) the HealthGate Series of Products are either HealthGate's own
and original creation or are validly licensed to HealthGate for use by others or
are in the public domain; (iii) it has full ownership of the HealthGate
Trademarks.
6.2 COMPLIANCE WITH LAWS. Except to the extent such obligation is
expressly assumed by VAR, HealthGate shall, at its own expense, comply with any
laws relating to the sale, lease, or license of the HealthGate Series of
Products, and shall procure all licenses and pay all fees and other charges
required thereby.
6.3 VAR REPRESENTATIONS AND WARRANTIES. VAR represents and warrants
that (i) it has the right to enter into this Agreement, (ii) VAR's agreements
with its Corporate/Institutional Accounts shall be consistent with the terms and
conditions of this Agreement; and (iii) VAR shall not commit HealthGate to
provide the HealthGate Series of Products or any other HealthGate Service or
product without HealthGate's express written consent.
6.4 COMPLIANCE WITH LAWS; PROHIBITION ON RESALE AND RELICENSING OF
PRODUCTS. In the
4
End-User Agreement and in other agreements, contracts and arrangements with its
Corporate/Institutional Accounts, VAR shall require each of its
Corporate/Institutional Accounts to limit its actions (including the actions of
its Authorized Users) and use of the HealthGate Series of Products to conform to
applicable laws regarding the export of re-export of any information, or any
process, product, or service, to countries specified as prohibited destinations,
including the Regulations of the U.S. Department of Commerce and/or the U.S.
State Department, to the extent applicable. Corporate/Institutional Accounts and
Authorized Users of the Co-Branded Site shall be prohibited from reselling or
re-licensing the HealthGate Series of Products or any portion thereof without
the express written consent of VAR and HealthGate (which consent may be withheld
for any reason or for no reason). VAR shall be responsible for enforcing this
prohibition and having appropriate written limitations of the use of the
HealthGate Series of Products with all its Corporate/Institutional Accounts or
other users of the Co-Branded Sites. VAR shall have all Authorized Users
register with VAR or the Corporate/Institutional Account in a manner acceptable
to HealthGate and such registration information shall be available for review by
HealthGate upon written request.
VII. NEW PRODUCTS AND QUARTERLY MUTUAL NON-DISCLOSURE
7.1 INCLUSION OF NEW HEALTHGATE PRODUCTS If during the term of this
Agreement, HealthGate develops or promotes new products or services (including
new content sources) which HealthGate offers for resale or licensing through
HealthGate's value added reseller network ("New VAR Products and Services"),
then HealthGate shall permit VAR to also promote, sell and license such New VAR
Products and Services.
7.2 QUARTERLY INFORMATIONAL MEETINGS. Representatives of HealthGate and
VAR shall meet quarterly to share information concerning products, services,
promotions, marketing and technical matters. The purpose of such meetings shall
be to plan for improvements to existing HealthGate Series of Products and to
coordinate future marketing and other activities. Neither party shall be
obligated to provide confidential information in such meetings; however, if
confidential information is disclosed in such meetings, the recipient of such
confidential information shall use reasonable care, but in no event no less than
the same degree of care that it uses to protect its own confidential and
proprietary information of similar importance, to prevent the unauthorized use,
disclosure, publication or dissemination of such confidential information.
Additionally, the recipient agrees it is accepting the confidential information
for the sole purpose of licensing and sales pursuant to this VAR Agreement and
the recipient agrees not to use such confidential information otherwise for its
own or any third party's benefit.
VIII. ADMINISTRATORS; CONTACT PERSONS.
8.1 ADMINISTRATORS. The parties each hereby designate an Administrator
to receive notices, and any other contact between parties pursuant to this
Agreement.
HealthGate's Administrator is:
------------------
HealthGate Data Corp.
000 Xxxxxxxx Xxxxxx, Xxxxx 000
Xxxxxx, XX 00000
5
0-000-000-0000 x____ (voice)
0-000-000-0000 (fax)
@xxxxxxxxxx.xxx (electronic mail)
---------
VAR's Administrator is:
-----------
-----------
(voice)
-----------
(fax)
-----------
(electronic mail)
-----------
Either party may change its Administrator pursuant to written notice to
the other party containing an express reference to this Agreement.
IX. DISPUTE RESOLUTION
9.1 GOOD FAITH DISCUSSIONS. The parties hereto agree to meet and confer
in good faith to resolve any problems or disputes that may arise under this
Agreement.
9.2 ARBITRATION. Any dispute or controversy between the parties,
including a fee dispute or a dispute arising from an alleged material breach of
this Agreement by a party, shall, on written request of one party served on the
other, be submitted to arbitration. Any arbitration shall be conducted before a
panel of three arbitrators in accordance with the then existing Rules for
Commercial Arbitration of the American Arbitration Association and judgment upon
any award rendered by the arbitrator(s) may be entered by any State or Federal
court having jurisdiction thereof. The parties intend that this agreement to
arbitrate be valid, enforceable and irrevocable. The decisions of the
arbitrators shall be final and conclusive upon all parties and judgment upon the
award may be entered in any court of competent jurisdiction. The arbitrators may
assess costs, including counsel fees, in such manner as they deem fair and
equitable. The arbitration shall be conducted in Boston, Massachusetts unless
otherwise mutually agreed by the parties.
9.3 INJUNCTIVE RELIEF. VAR acknowledges that in the event of a breach
of certain sections of this Agreement, including, without limitation Article V
and Sections 4.4(b) and 6.4, HealthGate may not have an adequate remedy at law
and may suffer irreparable damage and injury. Therefore, in addition to any
other remedy available, VAR agrees that if it violates any of the provisions of
Article V or Sections 4.4(b) or 6.4, HealthGate shall be entitled to seek
injunctive relief by a court of competent jurisdiction.
X. MISCELLANEOUS
10.1 CONFIDENTIAL INFORMATION. Unless otherwise agreed to in writing
signed by the authorized representatives of both parties, neither party shall
provide the other party with information that is confidential or proprietary to
itself or any third party. Accordingly, no obligation of confidentiality of any
kind is assumed by, or shall be implied against, either party
6
by virtue of its discussions and/or correspondence with the other party or with
respect to any information received (in whatever form or whenever received) from
the other party under this Agreement or in activities related thereto.
10.2 LIMITATIONS ON DAMAGES. Neither party shall be entitled to
indirect, incidental, or consequential damages, including lost profits based on
any breach or default under this Agreement. This limitation shall not apply to
any liabilities based on obligations to third parties. In no event shall
HealthGate be liable under this Agreement to VAR for damages exceeding the
amounts paid by VAR under this Agreement.
For any period of time in which the HealthGate Site is not available to
Authorized Users or not properly functioning through the Co-Branded Site due to
actions or inactions by HealthGate, VAR's remedy shall be limited to an
abatement of that portion of the License Fee attributable to the period of time
of which the HealthGate Site is unavailable or not functioning.
10.3. FREEDOM OF ACTION. Except as set forth in Section 2.2, nothing in
this Agreement shall be construed as prohibiting or restricting either party
from independently developing or acquiring and marketing materials and/or
programs that are competitive with the Co-Branded Sites.
10.4 INDEPENDENT CONTRACTOR. HealthGate and VAR are and shall remain
independent contractors with respect to all matters pursuant to the Agreement.
10.5 NO ASSIGNMENT. VAR may not sell, transfer, assign, or subcontract,
any right or obligation set forth in this Agreement without the express advance
written consent of HealthGate.
10.6 AMENDMENTS IN WRITING. No amendment, modification, or waiver of
any provision of this Agreement shall be effective unless it is set forth in a
writing that refers to this Agreement and is executed by an authorized
representative of both parties. No failure or delay by either party in
exercising any right, power, or remedy will operate as a waiver of any such
right, power, or remedy.
10.7 THIRD PARTY RIGHTS. This Agreement is not intended and shall not be
construed to create any rights for any third party.
10.8 FORCE MAJEURE. Neither party shall be liable nor deemed to be in
default of its obligations hereunder for any delay or failure in performance
under the Agreement or other interruption of Service resulting, directly or
indirectly, from acts of God, civil or military authority, act of the public
enemy, war, accidents, natural disasters or catastrophes, strikes, or other work
stoppages or any other cause beyond the reasonable control of the party affected
thereby. However, each party shall utilize it best good faith efforts to perform
such obligations to the extent of its ability to do so in the event of any such
occurrence or circumstances.
10.9 GOVERNING LAW. The validity, interpretation, and performance of
this Agreement shall be governed by and construed in accordance with the
internal laws and not the law of conflicts of the Commonwealth of Massachusetts.
7
10.10 ENTIRE AGREEMENT; SEVERABILITY. This Agreement, together with the
Schedules and other attachments referenced herein, contains a full and complete
expression of the rights and obligations of the parties. This Agreement
supersedes any and all other agreements, written or oral, made by the parties.
If any provision of this Agreement is finally held by a court or arbitration
panel of competent jurisdiction to be unlawful, the remaining provisions of this
Agreement shall remain in full force and effect to the extent that the parties'
intent can be lawfully enforced.
10.11 EXHIBITS. All exhibits and attachments referenced in this
Agreement are incorporated herein as though set forth in full. If any provision
of this Agreement conflicts with any Exhibit to this Agreement, this Agreement
shall control with respect to the subject matter of such Exhibit.
10.12 CAPTIONS & HEADINGS. The headings, titles and captions of the
sections of this Agreement and the Exhibits and Attachments are inserted only to
facilitate reference, and they shall not define, limit, extend or describe the
scope or intent of this Agreement or any provision hereof or any Exhibit or
Attachment hereto, and they shall not constitute a party hereof or affect the
meaning or interpretation of this Agreement or any part hereof.
10.13 OPERATION OF HOT SITE. HealthGate is currently investigating the
use of appropriate alternate sites for its data center. These sites will serve
as alternative sites or "hot sites" in the event of disaster or any other causes
of interruption of service at its data center facilities. Additionally, these
sites will serve as high-bandwidth access sites for HealthGate's international
clients and partners. VAR is encouraged to submit candidates for the hot sites,
including VARs data center(s).
10.14 YEAR 2000 - The PROGRAMS(S) requiring date data input of four
digit date years. Provided that input to the PROGRAM(S) comply with this
requirement, for each PROGRAM(S) shipped by VENDOR, VENDOR warrants to DGC
and to the END USER, if any, that the PROGRAM(S) shall, for a period that
commences on such shipment and expires ninety (90) calendar days successful
installation, or March 31, 2001, whichever occurs later, correctly process,
calculate, compare and xxxxxxxx xxxx from, into and between the twentieth and
twenty-first centuries, including leap-year calculations, when used in
accordance with its user documentation and published specifications and any
other requirements set forty in the applicable PROGRAM ATTACHMENT, provided
that all hardware and software used in combination with such PROGRAM(S)
properly exchange data therewith.
10.15 ESCALATION OF PROBLEMS. Both parties wish to work together to
assure an effective and efficient implementation, therefore both parties will
have the right to escalate any issue through the other party's organization if
they are not resolved in a timely manner. In the event that an issue cannot
be resolved by the parties' respective Program Manager ("PROGRAM MANAGER"),
the issue shall be referred to designated representatives of each party in
the following manner. B. To prevent any significant disruption in any work
for a PROGRAM ATTACHMENT, the following events will be automatically
escalated: (a) Tasks scheduled but not completed during the month and there
is a disagreement with respect to the source of delay and/or the rescheduling
of such tasks; and (b) Issues that may result in a material change in project
scope and therefore may require additional charges by VENDOR. Issues
involving changes in scope that may be billable include, but are not limited
to, the following: (a) requests for additional training or additional
tailoring assistance, (b) project delays greater than one month or (c)
material changes in the scope of interfaces and conversions. These issues
must be resolved to the mutual written agreement of both parties before any
material changes in scope are acted upon. C. The parties agree that
unresolved issues reported will be discussed within ten (10) business days by
the next level representatives identified in Exhibit 4 who shall work to
resolve the issues amicably and expeditiously. Issues that remain unresolved
will continue to be escalated to the next level of representatives in the
same manner. Should such issue not be resolved via this escalation process,
then the matter may be addressed in accordance with the Mediation of a
PROGRAM Attachment processes set forth below.
IN WITNESS WHEREOF, duly authorized representatives of the parties have
executed this Agreement as of the date first written above:
HEALTHGATE DATA CORP. DATA GENERAL CORPORATION (VAR)
By: /s/ XXXXXXX X. XXXXX By: /s/ XXXXXX X. XXXXXX
------------------------------- -----------------------------
Name: Xxxxxxx X. Xxxxx Name: Xxxxxx X. Xxxxxx
Title: Chief Executive Officer ---------------------------
Title: VP, Worldwide Healthcare
--------------------------
8
SCHEDULE A. TO VAR AGREEMENT
***DATA GENERAL CORPORATION***
THE HEALTHGATE SERIES OF PRODUCTS; LICENSE FEES & PRICES
The HealthGate Series of Products
The following collection of databases and content are available through
HealthGate to the VAR for relicensing.
Health Communication System Pricing
Patient and Consumer Package $20,000
--------------------------------------------------------------------------------
Consumer Series Content
Patient Series Content
Included Features:
o Customized "Web-zines" for front page of the articles
o Three article per magazine per month
o Standard "Send to a friend"
o Quarterly reports on the usage
o Authentication for Patient and Professionals
o 1500 authentication cards with hospital ID number
o Customized "Intelligent promotional" Service
o Includes hosting of up to 10 banner ads
o Customized "Commercial advertising and sponsorship" spots
Required customization and implementation (one-time,
non-discountable fee) $ 7,000
o A Standard design template
o Customized coloring scheme
o Customized sizing of the templates
o Customized logo placement
o Customized front page for each of the selected series
o Customized linking to and from the Institution's Web site
o Limited Customized authentication scheme, including combination of
o Linked URL
o Linked Domain address
o Password and Username
o Customized Quarterly usage report
o User support at HealthGate
Additional optional Features
o Printing Module for the Patient Series $ 2,000
o School Nurse Communication module $ 2,000
10
o Customized "Send to..." from the local address book $ 2,000
o Additional banner ads, package of 5 $ 1,000
o Resource Locator Module with content sensitive links $ 5,000
o Find a doctor
o Find a facility
o Find a service
Total $39,000
If the entire package, including the optional features, is
ordered in advance, the cost is discounted to:
$35,000
Professional Package $20,000
--------------------------------------------------------------------------------
Included Content
o MEDLINE
o AIDSLINE
o AIDSDRUGS
o AIDSTRIAL
o CANCERLIT
o BIOETHICSLINE
o HEALTHSTAR
o Drug Information Handbook
o PsycINFO; 5000 citations
o EMBASE; 2,000 citations
o CMEs unlimited for 100 physicians
o Cinahl
x Xxxxxx'x MedNews
o Detwilers Directory
x Xxxxx'x Book Review
Included Features
o Standard "Send to a friend"
o Quarterly reports on the usage
o Authentication for Professionals
o 750 authentication cards with hospital ID number
o "Intelligent promotional" Service
o Includes hosting of up to 10 banner ads
o Commercial advertising and sponsorship Module
11
Required customization and implementation $7,000**
(If the Professional Package is implemented with the Patient and Consumer
package this 2nd implementation fee is waived.)
Additional optional content or features
o Ageline $ 2,500
o Additional CMEs unlimited for 50 physicians $ 5,000
o Additional PsycINFO; 5,000 citations $ 3,000
o Additional EMBASE; 2,000 citations $ 3,000
o Customized "Send to a librarian" $ 1,000
Sub-total of options $14,500
Total with all options $34,500
**If implementation fee is required $41,500
All above prices are based on annual contracts and an average of 10,000 daily
page views for sponsorship-based licenses or 5,000 daily page views for
non-sponsorship-based licenses. (If a customer accepts sponsorship and
advertising on the Co-Branded Site, their package includes an extended per day
usage). For the purposes of this Agreement, a "Page View" is defined as each
HTML page, non-HTML page, or detailed record citation of the Products viewed by
the Authorized User of VAR's Corporate/Institutional Account(s). The "Usage" and
"Overage Fees" are described in Schedule E.
Description of the Patient and Consumer Series
The Patient Series
This series provides education materials for the organization's patient
population (including several in both English and Spanish), as well as a place
for patients to do independent research on conditions and diagnoses. The use of
this series is restricted to the organization's patient population. This series
is password protected and requires user registration.
Adult Health Advisor
Behavioral Health Advisor
Pediatric Health Advisor
Woman's Health Advisor
Seniors Health Advisor
Well-Connected Patient Education Reports
12
The Consumer Series
Content in the Consumer Series is available to users on healthcare
organization's internet, intranet and extranet sites via a link to the
"Co-Branded Site". This series is not password protected, does not require user
registration, and allows unrestricted access via the "Co-Branded Site".
Reuters Health eLine
The Wellness Center
Complete Guide to Prescription and Non-Prescription Drugs
MDX Complete Guide to Symptoms, Illness, and Surgery
DPH - Diagnostic Procedures Handbook
Healthy Eating
Healthy Parenting
Healthy Sexuality
Healthy Woman
Healthy Man
Healthy Mind
VAR and HealthGate agree that other content and databases may be added to the
Products upon written mutual agreement of both parties from time to time and in
writing. Additionally, HealthGate reserves the right to substitute a database or
content in the event a listed database or content become unavailable or cost
prohibitive as determined by HealthGate.
License Fees.
License Fees. The annual license fees for the Health Communication System
packages and features that comprise the HealthGate Series of Products payable by
are 70% of the fees listed above, excluding the customization and implementation
fee, which is non-discountable.
Payment and Invoicing of License Fees and Set-up Charges. Annual license
fees and set-up charges, as applicable, are payable by VAR to HealthGate upon
the execution of the End-User Agreement (Schedule E). VAR will remit a purchase
order and a signed and completed End-User Agreement for each
Corporate/Institutional Account. HealthGate will invoice VAR for such License
Fee(s) and Set-up charges.
Adjustments to Fees. HealthGate may adjust the license fees for the
Products at any time and from time to time twelve months after the effective
date of this Agreement and the adjustments shall be effective sixty (60) days
following written notice to VAR of the fee changes (the "Fee Adjustment Date").
Such fee adjustments shall be based solely on increases on HealthGate's
licensing and copyright cost. The adjustments to fees will not impact the
13
Corporate/Institutional Accounts with valid agreements during the initial term
of their contracts. Except as otherwise permitted in such contracts, the
adjustment to fees may, however, impact all new and renewal contracts that
become effective after the "Fee Adjustment Date".
Fees Related to Additional Products. Notwithstanding anything to the
contrary contained in the fee adjustment procedures described in this Agreement
or the fee schedule set forth above, any modification to the Products described
in this Schedule A may be accompanied by additional fees as determined by
HealthGate and approved in writing by VAR prior to initiation of such
modification.
14
SCHEDULE B TO VAR AGREEMENT
***DATA GENERAL CORPORATION***
ADVERTISING / SPONSORSHIP AND OTHER FEE ARRANGEMENTS
Commercial Advertising Spots and Promotional Spots
The Co-Branded Site allows for advertising and sponsorship messages to be
served to the Authorized Users of each Corporate/Institutional Account of the
VAR. The areas of the Co-Branded Site that are targeted for this function shall
be referred to as "Commercial Advertising and Sponsorship Spots". In the
End-User Agreement, each Corporate/Institutional Account of the VAR may accept
or reject this option.
Additionally, the Co-Branded Site allows for the Corporate/Institutional Account
to serve messages on behalf of itself, its donors, corporate and commercial
partners. The areas of the Co-Branded Site that are targeted for this function
shall be referred to as "End-User Promotional Spots".
End User Promotional Spots
The Corporate/Institutional Account shall have the exclusive right to sell and
market the End-User Promotional Spots of the Co-Branded Site to its internal
departments, its donors, corporate and commercial partners. HealthGate will
serve the messages on the End-user Promotional Spots of the Co-Branded Site for
a one-time fee of $100 per campaign ad or message.
The revenues associated with the End-User Promotional Spots of the
Co-Branded site are earned and retained exclusively by the
Corporate/Institutional Account. Except for the $100 campaign fee(s) noted
above, neither HealthGate nor the VAR participates in any share of such revenues
or affiliated expenses.
Commercial Advertising and Sponsorship Spots
If the Commercial Advertising and Sponsorship Spot option is selected by
VAR's Corporate/Institutional Account, HealthGate shall have the exclusive right
to sell and serve advertising on the Commercial Advertising and Sponsorship
Spots of the Co-Branded Site. The Corporate/Institutional Account will have the
right to approve or reject each advertiser or sponsor.
Allocation of Commercial Advertising and Sponsorship Spots Revenue
The revenues associated with the Commercial Advertising and Sponsorship
Spots of the Co-Branded site are earned and collected by HealthGate. HealthGate
shall share the Net Advertising and Sponsorship Revenue (as defined below)
associated with the Commercial Advertising and Sponsorship Spots with the VAR
and the Corporate/Institutional Account as set forth below. "Net Advertising and
Sponsorship Revenue" shall equal all advertising and sponsorship revenue
actually collected for the Co-Branded Site, less HealthGate's reasonable
expenses associated with such advertising revenue, provided such reasonable
expenses shall not
15
exceed 20% of such advertising and sponsorship revenue.
--------------------------------------------------------------------------------
Net Advertising and HealthGate's VAR's Corporate/Institutional
Sponsorship share Share Account's share
Revenue
--------------------------------------------------------------------------------
$0 to twice the 40% 10% 50%
amount paid by the
end-user for the
HealthGate
collection
--------------------------------------------------------------------------------
Over twice the 90% 10% 0%
amount paid by the
end-user for the
HealthGate
collection
--------------------------------------------------------------------------------
Commercial Advertising and Sponsorship Spots Statements and Payments
HealthGate will render a quarterly statement ("Statement") to VAR and its
Corporate/Institutional Account of the sales and collections of Commercial
Advertising and Sponsorship Spots revenue relating to the Co-Branded Site within
thirty (30) days after the end of a quarter. Payments to VAR and its
Corporate/Institutional Account for their respective share of Net Advertising
and Sponsorship Revenue that has been collected by HealthGate shall accompany
each Statement for the reported period.
Finder's fee for Advertising and Sponsorship
In addition to the above schedules, VAR will earn a Finder's fee for
introducing and facilitating the sale of advertising and sponsorship on a
Co-Branded Site to the VAR's corporate clients and partners. Each of these
introductions needs to be registered in writing with HealthGate. Within 10 days
of such registration, HealthGate will notify the VAR of the eligibility of the
account for Finder's fees (without limiting the requirement for eligibility,
potential advertisers which HealthGate has already contacted prior to VAR's
introduction shall not be eligible for finder's fees). VAR will earn a finder's
fee, for all eligible accounts, equal to 10% of the first two years of
advertising and sponsorship revenues collected through transaction with the
referred eligible accounts. The reporting and payment for all such finder's fees
shall be included in the quarterly Statements reporting on Commercial
Advertising and Sponsorship Spots revenue.
Audit Rights
During the Term of this Agreement and for a period of one (1) year
thereafter, VAR and HealthGate will each maintain accurate and complete books
and records, including copies of all customer and other correspondence, relating
to such party's performance of its obligations under this Agreement.
16
Both parties will have the right, no more than once in any twelve (12)
month period, to audit the other party's books and records which are relevant to
this Agreement as provided for herein upon ten (10) days' prior written notice;
provided however, such audit shall not unreasonably interfere with the business
of either party. Such audits shall be conducted solely by an independent CPA
(Certified Public Accountant) firm hired on other than a contingency fee basis.
17
SCHEDULE C TO VAR AGREEMENT
***DATA GENERAL CORPORATION***
SETUP CHARGES, PROFESSIONAL SERVICES AND CUSTOM DEVELOPMENT
Setup Charges
HealthGate will design, develop, host and maintain the Co-Branded Sites for
VAR's Corporate/Institutional Accounts. HealthGate offers customization from a
broad selection of design templates and standard functions to address rapid
development requirements of most clients. Each Co-Branded Site has an affiliated
setup charge of $7,000 that includes:
o A Standard design template
o Customized coloring scheme
o Customized sizing of the templates
o Customized logo placement
o Customized front page for each of the selected series
o Customized front page for the Healthy web-zines
o Customized linking to and from the Corporate/Institutional Account's
WEB site
o Customized "End-user promotion" spots
o Customized "Commercial advertising and sponsorship" spots
o Limited Customized authentication scheme
o Linked URL
o Linked Domain address
o Password and Username
o Customized Quarterly usage report
o Send-to-a-friend and send-to-a-colleague functions
o User support at HealthGate
Professional Services and Custom Development
HealthGate offers additional customization services beyond what is described in
the above Setup Charges. These additional services are treated as separate
projects and HealthGate will assist the VAR in defining a Statement of Work and
pricing the Custom Development effort per project. Examples of such services
are:
o Corporate/Institution Account Web-site design and development
o Corporate/Institution Account Web-site hosting
o Integration of the Co-Branded Site with other Corporate/Institution
Account's applications
o Personalization functions
o Commissioning of customized articles and editorials for the Co-Branded
Site
18
SCHEDULE D TO VAR AGREEMENT
***DATA GENERAL CORPORATION***
VAR Territory
VAR Territory
In consideration of VAR's acceptance of a proposal sent to Xxxxx Xxxxx, from a
period beginning June 1, 1998 and continuing until June 30, 1999, VAR has the
exclusive right to resell the HealthGate product and services listed in
Schedules A and C to its current installed base of MEDITECH hospitals. The
installed base is defined as any MEDITECH/Data General account, world-wide, that
has purchased Data General equipment, software or services in conjunction with a
MEDITECH system. If any new MEDITECH/Data General account, has already been a
HealthGate customer either directly through HealthGate or another re-seller,
then the customer has the right to continue to purchase from its original
source, or Data General.
Renewal of Exclusive Territory
If VAR has successfully sold twenty-five (25) accounts (including the thirteen
(13) accounts described in the above-mentioned proposal accepted by VAR) by June
30, 1999, the exclusive territory will be renewed for another conditional 6
months. In the event that VAR sells fewer than 25 licenses by June 30, 1999, the
exclusive right shall revert to a non-exclusive right for the remainder of this
Agreement, as defined in section 4.1 of this Agreement.
19
SCHEDULE E OF SUPPORT SERVICES
The following sets forth the SUPPORT SERVICES to be provided to DGC by VENDOR
for PROGRAM(S) for which DGC is entitled to receive SUPPORT SERVICES in
accordance with the applicable PROGRAM ATTACHMENT, and payment by DGC of the
applicable annual Support Services Fees, provided in the Program Attachment, for
EACH End User licensed by or through DGC.
1. DEFINITIONS
A. "UPDATE" - means any subsequent release of or change to each
PROGRAM(S), containing a bug fix, enhancement, modification, or addition
to the functionality or specifications of the immediately prior release,
which does not meet the requirements for designation as a VERSION.
B. "VERSION" - means any subsequent release of or change to a PROGRAM(S)
that contains a substantial functional enhancement to the immediately
prior release and is marketed by VENDOR in the following manner:
1) such release is made generally available to VENDOR's customers
under a model number or designation different from that used for the
immediately prior release, and
2) such release is made generally available to users of the
immediately prior release at a charge that is separate from and in
addition to both the original licensing fee and the usual and
customary support fees charged for support and bug fixes by VENDOR,
and
3) VENDOR continues to separately market and support only the
immediately prior release, while also offering support and bug fixes
for such subsequent release.
2. NAMED CONTACTS
DGC shall designate in writing, as the only DGC representatives authorized
to contact VENDOR's support center, the names of one Primary and one
Secondary Support Contact. DGC reserves the right to change such names
when appropriate.
3. SCOPE
DGC will provide the point of first-call contact to DGC customers. VENDOR
will provide the services described herein ("SUPPORT SERVICES") to DGC.
DGC will have access to any expanded services, service locations and
service hours that VENDOR makes available to its other distributors. The
right to use and distribute UPDATES for previously issued licenses for
PROGRAM(S) is included in the related SUPPORT SERVICES Fees for each End
User as provided in the Program Attachment. Payment of the SUPPORT
SERVICES Fee does not entitle DGC to receive or distribute VERSIONS at no
additional charge from VENDOR. DGC is not obligated to obtain or
distribute any VERSION but VENDOR is only obligated to support the then
current and the immediately prior release. VENDOR agrees, at its then
current standard charges and terms, to make enhancements, changes,
modifications, and additions to PROGRAM(S), in addition to those required
or provided by SUPPORT SERVICES, as may be reasonably requested by DGC.
4. NOTICE AND FORMAT
Prior to issuing any new release, VENDOR shall send DGC notice of the
existence of a new release, specifying the exact release designation to be
used by VENDOR for such release.
20
Each new release of PROGRAM(S) shall demonstrate i) compatibility with the
applicable computer hardware and related operating system, and iii)
compliance with VENDOR's internal quality control and assurance
procedures. UPDATES containing relatively minor changes may be made
available with the documentation changes specified in a separate release
notice. UPDATES that contain major modifications or enhancements, and
VERSIONS, shall be made available with the changes integrated into a
revised set of documentation. VENDOR shall notify DGC in writing, no later
than the shipment date thereof, of the problems that are solved and those
that remain therein, and shall send documentation appropriate thereto. The
new release shall be supplied as an installable module or a complete
release, and sent to End User(s) on magnetic media or as an electronically
transferred file to a End User(s) End User(s) host computer.
5. SUPPORT PERIOD
The Support Period shall be for one year from the date of payment of the
applicable Support Services Fee(s).
6. BETA-TESTING
At DGC's request, VENDOR shall evaluate DGC for use as a beta-test site
for UPDATES and VERSIONS.
7. PHONE-CALL SUPPORT
Phone-call support allows DGC's technical support to obtain information
directly from VENDOR's support organization. This service is used in
connection with the following:
A. Telephone Support Hot-line - VENDOR answers DGC's calls related
to operation, sysgen and installation, configuration, documentation,
general product information, and Software Trouble Reporting (STR)
and Resolution services. The hotline service will be available from
8 A.M. to 8:00 P.M. Eastern Time. With regard to PROGRAM(S), DGC
will attempt to reproduce the problem and DGC shall not normally
contact VENDOR's support organization if the problem is i) related
to installation, ii) covered in a listing of known problems and
responses previously provided by VENDOR to DGC, or iii) caused by a
defect or problem in DGC hardware or the DG/UX operating system.
B. Product Newsletter - DGC provides and uses for support purposes
an on-line product newsletter describing proposed changes, future
releases, information on compatibility and third party software or
hardware, tips and techniques, articles, and known problems and
solutions not covered in the STR database, as well as general
information. VENDOR will provide relevant information to DGC, of the
type that VENDOR generally provides to its other distributors and
users, for inclusion in this newsletter.
C. Known Problems - VENDOR will provide DGC with information
concerning known problems, including, but not limited to, a
description, workarounds, and fixes.
D. Monthly Summary of Escalated Calls - VENDOR agrees to summarize
all responses to all unresolved STRs in a monthly written report
that will be provided to DGC within ten (10) days after the end of
each month, and shall include a description of the specific problem
resolution actions taken or contemplated, and the status of VENDOR's
remedial efforts and anticipated time of solution.
8. TROUBLE REPORTING AND RESOLUTION
The following process will be used in the support of the DGC customers the
VENDOR and DGC. The VENDOR will establish a 1-800 pager number and email
address to facilitate the exchange of information with the DGC customer
support center. The VENDOR will be
21
responsible to provide customer service delivery for their application
programs until the service call is closed by the DGC customer support
center.
The Service Call Process:
A. Customer contacts DGC support center via 1 800 DGHELPS
hotline.
B. DGC support personnel perform initial problem determination in
order to establish if the problem is a DG hardware, DG system
software or VENDOR software related. If the problem is DG
hardware or system software related DG is responsible to
render service to the customer.
C. If DGC's support organization believes the problem is related
to the VENDORS software, the DGC support center will
electronically email the VENDOR a document detailing the
problem and including DGC's service request reference numbers.
D. DGC will follow up the email by paging the VENDORS on call
support organization. The page will detail a phone number at
which the VENDORS support organization can reach the DGC
representative who is in contact with the customer. The DGC
and VENDOR representatives will discuss the service problem
and establish if the VENDOR will now take responsibility for
the service call.
E. In the event the service problem is the VENDORS
responsibility, the VENDOR will contact the DGC customer and
render service.
F. When the service problem is corrected by the VENDOR, the
VENDOR will electronically email a call closed report to the
DGC customer support center detailing the action required to
fix the problem.
G. The DGC customer support center will then close the service
call.
H. In the event that the VENDOR determines that the service
problem is a DGC hardware or system software problem then the
VENDOR will call the 1 800 DGCHELPS hotline and use the
reference number that has been sent to the VENDOR via email
for this service problem to inform DGC customer support center
that the problem remains open and requires DGC attention. The
VENDORS responsibility for the call will remain open until the
DGC customer support center verifies the problem is DGC
harware or system software related.
9. COMMUNICATION MECHANISM
With the mutual consent of both parties, communication between the two
companies will be by electronic mail and direct file transfer. Data
transmission between the two systems shall be by common carrier.
Additional communication links may be established.
10. ADDITIONAL SUPPORT
VENDOR hereby agrees to provide DGC with reasonable assistance in order
for DGC to respond to requests for bids or demonstrations involving
PROGRAM(S).
22
